Cytokinetics Inc (CYTK)
51.48
-0.34
(-0.66%)
USD |
NASDAQ |
Nov 04, 16:00
51.50
+0.02
(+0.04%)
After-Hours: 20:00
Cytokinetics Profit Margin (Quarterly): -57.56K% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -57.56K% |
| March 31, 2024 | -16.24K% |
| December 31, 2023 | -8.19K% |
| September 30, 2023 | -34.24K% |
| June 30, 2023 | -14.84K% |
| March 31, 2023 | -2.85K% |
| December 31, 2022 | -7.02K% |
| September 30, 2022 | -5.66K% |
| June 30, 2022 | -22.28% |
| March 31, 2022 | -7.79K% |
| December 31, 2021 | -54.98% |
| September 30, 2021 | -1.40K% |
| June 30, 2021 | -2.17K% |
| March 31, 2021 | -719.4% |
| December 31, 2020 | -653.5% |
| September 30, 2020 | -7.62% |
| June 30, 2020 | -1.13K% |
| March 31, 2020 | -1.03K% |
| December 31, 2019 | -587.9% |
| September 30, 2019 | -488.4% |
| June 30, 2019 | -450.0% |
| March 31, 2019 | -347.0% |
| December 31, 2018 | -282.3% |
| September 30, 2018 | -206.9% |
| June 30, 2018 | -442.8% |
| Date | Value |
|---|---|
| March 31, 2018 | -574.8% |
| December 31, 2017 | |
| September 30, 2017 | -523.6% |
| June 30, 2017 | -952.5% |
| March 31, 2017 | -622.9% |
| December 31, 2016 | 21.60% |
| September 30, 2016 | 56.50% |
| June 30, 2016 | -200.1% |
| March 31, 2016 | -147.9% |
| December 31, 2015 | -94.59% |
| September 30, 2015 | -111.4% |
| June 30, 2015 | -161.3% |
| March 31, 2015 | -201.0% |
| December 31, 2014 | 38.80% |
| September 30, 2014 | -63.42% |
| June 30, 2014 | -107.5% |
| March 31, 2014 | -109.6% |
| December 31, 2013 | 26.82% |
| September 30, 2013 | -281.7% |
| June 30, 2013 | -1.49K% |
| March 31, 2013 | -1.54K% |
| December 31, 2012 | -524.5% |
| September 30, 2012 | -586.0% |
| June 30, 2012 | -485.8% |
| March 31, 2012 | -545.5% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-57.56K%
Minimum
Jun 2024
-7.62%
Maximum
Sep 2020
-8.53K%
Average
-2.17K%
Median
Jun 2021
Profit Margin (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | -22.27% |
| Biomarin Pharmaceutical Inc | 14.22% |
| Catalyst Pharmaceuticals Inc | 33.24% |
| Sarepta Therapeutics Inc | 1.78% |
| Ocugen Inc | -1.34K% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -58.30% |
| Return on Invested Capital | -163.9% |
| Gross Profit Margin (Quarterly) | -31.87K% |
| Operating Margin (Quarterly) | -52.28K% |
| Return on Net Operating Assets | -360.6% |